Mon, May 19, 9:24 PM (28 days ago)
**Immix Biopharma, Inc. (IMMX) - 10-Q/A Summary** **Company Overview:** Immix Biopharma, Inc. (IMMX) is a biopharmaceutical company based in Los Angeles, CA. As of May 6, 2025, it had 27,877,293 shares of common stock outstanding. **Form 10-Q/A Amendment:** This amendment (No. 1) to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, is filed to include certifications of the Principal Executive Officer and Principal Financial Officer, which were inadvertently omitted from the original report. No other changes have been made to the original Form 10-Q. **Financial Health and Performance:** The amendment does not provide updated financial information or changes to the previously reported financial data. Therefore, the financial health, performance metrics, revenue, profit margins, cash flow, and earnings changes remain as disclosed in the original Form 10-Q filed on May 8, 2025. **Future Operations:** The amendment does not reflect events that may have occurred subsequent to the original filing date and does not modify or update disclosures made in the Original Form 10-Q. For the latest financial information and trends, refer to the original Form 10-Q and other filings with the SEC. **Uncertainties:** The amendment does not address any new uncertainties or risks. For a discussion of risks and uncertainties, refer to the original Form 10-Q and other SEC filings. **Conclusion:** This amendment is primarily administrative, adding required certifications. For a comprehensive understanding of IMMX's financial health and performance, portfolio managers, traders, and finance professionals should review the original Form 10-Q and other relevant SEC filings.